The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
DLH HLDGS CORP | COM | 23335Q100 | 94 | 47,999 | SH | OTR | 47,999 | 0 | 0 | ||
ECHO THERAPEUTICS INC | COM NEW | 27876L906 | 804 | 377,633 | SH | OTR | 377,633 | 0 | 0 | ||
INSPIREMD INC | COM NEW | 45779A309 | 8 | 24,453 | SH | OTR | 24,453 | 0 | 0 | ||
NAVIDEA BIOPHARMACEUTICALS I | COM | 63937X103 | 18,213 | 11,454,831 | SH | OTR | 11,454,831 | 0 | 0 | ||
PEDEVCO CORP | COM NEW | 70532Y204 | 28 | 34,444 | SH | OTR | 34,444 | 0 | 0 | ||
VIRCO MFG CO | COM | 927651109 | 185 | 68,179 | SH | OTR | 68,179 | 0 | 0 |